share_log

Canaccord Genuity Assumes Theratechnologies at Hold, Announces Price Target of $2

Benzinga ·  Jul 3, 2023 09:02

Canaccord Genuity analyst Edward Nash assumes Theratechnologies (NASDAQ:THTX) with a Hold rating and announces Price Target of $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment